Double Billing, Silent Watchdogs: Inside the Medicare-Medicaid Fraud Network Exploiting Public Health Dollars and Silencing Whistleblowers

In the largest federal health care fraud takedown in U.S. history, the Justice Department and the Office of Inspector General charged 324 defendants in 2025 for schemes targeting Medicare and Medicaid, accounting for over $14.6 billion in intended losses, according to a Justice Department press release. These schemes, uncovered across multiple states, relied on fraudulent claims for unnecessary services or fabricated treatments, compounded by weak oversight and enforcement. Yet the story is not limited to isolated bad actors; the broader picture reveals structural gaps that make public insurance programs vulnerable to systematic abuse.

California, in particular, has become a focal point for exploitation. According to federal findings, fraudulent billing through Medicaid often originates from upcoding—the practice of assigning unnecessarily high billing codes—phantom claims for services never delivered, and kickbacks tied to patient referrals. The complexity of billing rules combined with inadequate auditing creates an environment in which fraudulent activity not only persists but flourishes. In New York, investigators have exposed rings of phantom clinics designed to exploit Medicaid through identity theft, costing millions of taxpayer dollars. On the other side of the country, Oregon has seen $445 million in improperly paid Medicaid benefits for residents concurrently enrolled in other states, according to an audit by the Oregon Secretary of State's Office.

The systemic nature of these abuses reveals that Medicare and Medicaid fraud is less about rogue actors and more indicative of institutional vulnerabilities, particularly in oversight frameworks. In Maine, a federal audit by the HHS Office of Inspector General revealed the state made $45.6 million in improper Medicaid payments for autism services in 2023. The audit identified missing documentation, failures to meet parent-consent requirements for treatment plans, and the use of non-credentialed providers for rehabilitative care. Maine has also been implicated in billing spikes for interpreter services that, according to state reviews, included charges for non-qualified staff and cases where interpreters falsely claimed hours for patients who didn’t need language assistance—a violation of Medicaid rules.

Whistleblowers often play a critical role in identifying these abuses, yet they frequently face retaliation or are coerced into silence through non-disclosure agreements and legal threats. A former employee of a behavioral health provider in North Carolina reported systemic overbilling for Medicaid-covered psychotherapy treatments, only for the claims to be dismissed by executives as the company continued to run what investigators later described as one of the state's largest fraudulent billing operations. Over three years, the state’s largest behavioral health practice, Mindpath Care Centers, allegedly billed for unprovided or undocumented services, culminating in a $1.9 million settlement in 2025 stemming from whistleblower allegations, according to the U.S. Department of Justice.

North Carolina has also been plagued by kickback schemes that exploit society’s most vulnerable. A federal investigation uncovered a $14.5 million scheme tied to a single company, Cedric Dean Holdings, which targeted Medicaid beneficiaries in homeless shelters and sold their Medicaid ID numbers for fraudulent claims, according to an FBI investigation reported by WBTV Charlotte. A similar federal takedown charged several providers in eastern North Carolina with kickbacks to patients who participated in substance abuse services—monetizing public funds meant to aid recovery.

These cases highlight the intersecting failures of state and federal oversight. States rely heavily on self-reported billing and have failed to implement comprehensive audit mechanisms. Federal and state oversight systems, including the Centers for Medicare and Medicaid Services (CMS) and Medicaid Fraud Control Units (MFCUs), are tasked with monitoring a trillion-dollar network of public insurance spending, yet they lack the resources to operate in real-time. Public data-sharing systems between states and the federal government are outdated, contributing to issues like the costly duplicate Medicaid enrollments identified in Oregon.

Weakening public oversight are the institutional incentives allowing fraudulent practices to persist. Medicaid's joint state-federal funding structure effectively rewards states for spending programs at greater velocity, diverting attention from compliance monitoring. This problem is exacerbated by the use of managed care organizations (MCOs), which earn payments per patient rather than by the service provided, creating a layer of complexity that shields improper payments from scrutiny.

Taxpayers ultimately bear the mounting cost, but what remains less discussed are the health risks posed to patients. In many cases, beneficiaries are subjected to unnecessary procedures, invasive tests, and even hospitalizations—all toward inflating provider reimbursements. The integrity of public health systems suffers, and trust in these programs erodes, with consequences for the low-income seniors and vulnerable patients they’re designed to support.

Legislative and political resistance further complicates anti-fraud efforts. In Maine, questions loom over reports that the state’s health department instructed staff not to cooperate with federal fraud investigations, as alleged by investigatory reporter Steve Robinson on Twitter. Similarly, the expansion of Medicaid in North Carolina to cover 600,000 more people in 2023 now exposes a wider pool to potential exploitation, against a backdrop of historically high improper-payment rates estimated at 20%.

What happens next in both enforcement and policy remains in question. While whistleblower protections under the False Claims Act are essential to uncovering fraudulent billing schemes, retaliation has muted crucial voices. At the structural level, CMS audits and federal penalties for the return of unqualified reimbursement funds have increased. Yet, in the face of complex billing systems and institutional complacency, vulnerabilities persist.

The stakes are clear: public insurance represents one of the most expansive federal expenditures, totaling $1.8 trillion annually. Without improved oversight and accountability, fraud in Medicare and Medicaid poses a direct threat to taxpayer resources, program viability, and, most importantly, patient well-being. Citizens—not systems—stand to bear the cost of inaction.